Entering text into the input field will update the search result below

Acasti Pharma reports FQ4 results

  • Acasti Pharma (NASDAQ:ACST): FQ4 EPS of -$0.18
  • Revenue of $21K (-88.2% Y/Y).
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ACST
--
ACST:CA
--